Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression

Ben L. Kong; Jayne M. Stommel; Jamie M. Keck; David Kilburn; Aaron Streblow; Julian Egger; Allison L. Creason; Christopher G. Suciu; Alexander R. Guimaraes; Christopher L. Corless; Gordon B. Mills; Tanja B. Pejovic

doi:10.1200/PO.23.00686

Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression

Ben L. Kong
, Jayne M. Stommel
, Jamie M. Keck
, David Kilburn
, Aaron Streblow
, Julian Egger
, Allison L. Creason
, Christopher G. Suciu
, Alexander R. Guimaraes
, Christopher L. Corless
, Gordon B. Mills
, Tanja B. Pejovic

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Article number	e2300686
Journal	JCO Precision Oncology
Volume	8
DOIs	https://doi.org/10.1200/PO.23.00686
State	Published - Jun 1 2024

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/PO.23.00686

Cite this

Kong, B. L., Stommel, J. M., Keck, J. M., Kilburn, D., Streblow, A., Egger, J., Creason, A. L., Suciu, C. G., Guimaraes, A. R., Corless, C. L., Mills, G. B., & Pejovic, T. B. (2024). Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression. JCO Precision Oncology, 8, Article e2300686. https://doi.org/10.1200/PO.23.00686

Kong, BL, Stommel, JM, Keck, JM, Kilburn, D, Streblow, A, Egger, J, Creason, AL, Suciu, CG , Guimaraes, AR , Corless, CL , Mills, GB & Pejovic, TB 2024, 'Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression', JCO Precision Oncology, vol. 8, e2300686. https://doi.org/10.1200/PO.23.00686

@article{fbb613f30b514e058edf340cc4b523ba,

title = "Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression",

author = "Kong, \{Ben L.\} and Stommel, \{Jayne M.\} and Keck, \{Jamie M.\} and David Kilburn and Aaron Streblow and Julian Egger and Creason, \{Allison L.\} and Suciu, \{Christopher G.\} and Guimaraes, \{Alexander R.\} and Corless, \{Christopher L.\} and Mills, \{Gordon B.\} and Pejovic, \{Tanja B.\}",

year = "2024",

month = jun,

day = "1",

doi = "10.1200/PO.23.00686",

language = "English (US)",

volume = "8",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression

AU - Kong, Ben L.

AU - Stommel, Jayne M.

AU - Keck, Jamie M.

AU - Kilburn, David

AU - Streblow, Aaron

AU - Egger, Julian

AU - Creason, Allison L.

AU - Suciu, Christopher G.

AU - Guimaraes, Alexander R.

AU - Corless, Christopher L.

AU - Mills, Gordon B.

AU - Pejovic, Tanja B.

PY - 2024/6/1

Y1 - 2024/6/1

UR - https://www.scopus.com/pages/publications/85200418801

UR - https://www.scopus.com/pages/publications/85200418801#tab=citedBy

U2 - 10.1200/PO.23.00686

DO - 10.1200/PO.23.00686

M3 - Article

C2 - 38905574

AN - SCOPUS:85200418801

SN - 2473-4284

VL - 8

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - e2300686

ER -

Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this